Study |
Reason for exclusion |
Axelsen 2015 |
Duplicate of Horslev 2014 |
Bathon 2000 |
Duplicate of Genovese 2002 |
Bejarano 2008 |
Wrong drug exposure |
Bonafede 2015 |
Not a RCT |
Boyle 2015 |
Wrong drug exposure |
Breedveld 2006 |
Wrong drug exposure |
Bresnihan 1998 |
Wrong drug exposure |
Burmester 2014 |
Comparing two routes of administration of a biologic |
Burmester 2015 |
Wrong drug exposure |
Cheng 2014 |
Conference abstract |
Cohen 2003 |
Wrong drug exposure |
Cohen 2006 |
Wrong drug exposure |
Coombs 2009 |
Wrong drug exposure |
Conaghan 2014 |
Sub‐study of Huizinga 2015 |
Dougados 2014 |
Duplicate of Huizinga 2015 |
Doyle 2013 |
Wrong drug exposure |
Durez 2004 |
Wrong drug exposure |
Emery 2008 |
Wrong drug exposure |
Emery 2014a |
Duplicate |
Emery 2014b |
Conference abstract |
Erickson 2015 |
Follow‐up at two years of Vollenhoven 2012 NCT00764725
|
Fleischmann 2012a |
Comparing multiple doses of a biologic |
Fleischmann 2012b |
Comparing multiple doses of biologics |
Fleischmann 2013 |
Conference abstract |
Furst 2015 |
Open label study |
Gabay 2013 |
Comparing two doses of a biologic |
Genovese 2002 |
Wrong drug exposure |
Genovese 2005 |
Wrong drug exposure |
Genovese 2015 |
Wrong drug exposure |
Gherge 2014 |
Conference abstract |
Haroui 2014 |
Duplicate of Pope 2014 |
Heimans 2014 |
Wrong drug exposure |
Hobbs 2015 |
Wrong drug exposure |
Hørslev‐Petersen 2014 |
Open label study |
Iannone 2014 |
Open label study |
Johnsen 2006 |
Wrong drug exposure |
Jones 2010 |
Wrong drug exposure |
Kameda 2011 |
Wrong drug exposure |
Kavanaugh 2014 |
Conference abstract |
Kennedy 2014 |
Wrong drug exposure |
Keystone 2014 |
Conference abstract |
Koroleva 2014a |
Conference abstract |
Koroleva 2014b |
Conference abstract |
Kremer 2015 |
Cross over study design |
Kremer 2009 |
Wrong drug exposure |
Kremer 2013 |
Wrong drug exposure |
Landewe 2015 |
Conference abstract |
Manders 2015 |
Trial patients switched therapy within one year/before completion of study period |
Mathias 2000 |
Wrong drug exposure |
McInnes 2015 |
Compares lipid levels in those randomzied to CZP or PL, in MTX‐IR patients |
Miyasaka 2008 |
Wrong drug exposure |
Moreland 1999 |
Wrong drug exposure |
Moreland 2002 |
Wrong drug exposure |
Navarro 2014 |
Conference abstract |
Nishimoto 2004 |
Wrong drug exposure |
Nishimoto 2007 |
Wrong drug exposure |
Oakley 2014 |
Conference abstract |
Ostergaard 2015 |
Wrong drug exposure |
Quinn 2005 |
Wrong drug exposure |
Pavelka 2013 |
Sub‐group analysis of Smolen 2013 NCT00565409
|
Smolen 2014 |
Patients in the control group also received the intervention |
Sonomoto 2014 |
Open label study |
St Clair 2004 |
Wrong drug exposure |
Tada 2012 |
Wrong drug exposure |
Takeuchi 2013a |
Wrong drug exposure |
Takeuchi 2013b |
Wrong drug exposure |
Takeuchi 2013c |
Wrong drug exposure |
Takeuchi 2014 |
Wrong drug exposure |
Van de Putte 2003 |
Wrong drug exposure |
Van de Putte 2004 |
Wrong drug exposure |
Van Vollenhoven 2009 |
Duplicate of Van Vollenhoven 2012 |
Vital 2015 |
B cell depletion study |
Weinblatt 2007 |
Wrong drug exposure |
Weinblatt 2014 |
Results at 1 year of Weinblatt 2013b GO‐FURTHER trial, NCT00973479
|
Westhovens 2014 |
Conference abstract |
Yamamoto 2014b |
Wrong drug exposure |
Yamanaka 2014 |
Post hoc analysis of Takeuchi 2014 |